ENSPRYNG (satralizumab-mwge) is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are AQP4-IgG(+).

PROVEN IN 2 CLINICAL STUDIES

Learn about efficacy and safety results for ENSPRYNG

A SUBCUTANEOUS INJECTION YOU CAN TAKE AT HOME

Learn how to take ENSPRYNG after proper guidance

FINANCIAL ASSISTANCE, RESOURCES, AND MORE

Get valuable information, resources, and community support